unknown
Stage
About
Edity develops an AI-powered immune cell delivery platform that engineers therapeutic proteins for targeted intracellular delivery, aiming to treat diseases including solid tumors by reprogramming the tumor microenvironment.
Explore Edity's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.